Confusion, dementia and anticholinergics in Parkinson's disease
- PMID: 7161613
- PMCID: PMC491705
- DOI: 10.1136/jnnp.45.12.1161
Confusion, dementia and anticholinergics in Parkinson's disease
Abstract
Among a population of 75 hospitalised Parkinsonian subjects, confusional states were observed in 46% of demented patients not receiving anticholinergic drugs and in 93% of demented patients under anticholinergic therapy. The sensitivity of demented Parkinsonians to anticholinergic drugs can be attributed to a cholinergic deficiency which has been detected in the cortex and hippocampus of Parkinsonian patients post-mortem. The observations suggest that anticholinergic medication should be avoided in Parkinsonians with intellectual impairment.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical